FOLH1 and posterior cortical atrophy: Previously, our group developed a first-generation photosensitizer-based dual-labeled PSMA ligand for intra-operative imaging and therapy of PCa called PSMA-N064, which showed the potential of this approach in PSMA-positive xenografts [23].